Abstract
Hypoxia inducible factor-1 (HIF-1) is a master regulator under conditions of decreased oxygen availability. As a hypoxia inducible transcription factor HIF-1 is a heterodimer composed of the helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF- 1α and the aryl hydrocarbon nuclear translocator (ARNT) also known as HIF-1β. The HIF-1 transcriptional system senses decreased oxygen availability and transmits this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, an altered energy metabolism, as well as cell survival decisions. Among recent advances are the discoveries that reactive nitrogen species (RNS), oxygen species (ROS), cytokines, and growth factors participate in stability regulation of HIF-1α and HIF-1 transactivation during normoxia. Here we summarize current knowledge and existing concepts that help to understand how NO affects protein accumulation of HIF-1α. Considering the fundamental role of radicals, especially NO, as signaling molecules makes HIF-1α an attractive target under conditions of NO formation that may be attributed to both, physiology and pathology. Although initial observations showed that NO inhibits hypoxia-induced HIF-1α stabilization and HIF-1 transcriptional activation, later studies indicated that exposure of various cells to chemically diverse NO donors or conditions of endogenous NO formation under normoxic conditions induced HIF-1α accumulation, HIF-1-DNA binding, and activation of downstream target gene expression. These contrasting situations evoked by NO provide insights into basic chemical reactions, biochemical signal transduction pathways with broad implications for medicine.
Keywords: hypoxia, phosphatidylinositol 3 kinase, akt, s-nitrosation, proteasome, superoxide
Current Medicinal Chemistry
Title: The Role of Nitric Oxide (NO) in Stability Regulation of Hypoxia Inducible Factor-1α (HIF-1α)
Volume: 10 Issue: 10
Author(s): Bernhard Brune and Jie Zhou
Affiliation:
Keywords: hypoxia, phosphatidylinositol 3 kinase, akt, s-nitrosation, proteasome, superoxide
Abstract: Hypoxia inducible factor-1 (HIF-1) is a master regulator under conditions of decreased oxygen availability. As a hypoxia inducible transcription factor HIF-1 is a heterodimer composed of the helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF- 1α and the aryl hydrocarbon nuclear translocator (ARNT) also known as HIF-1β. The HIF-1 transcriptional system senses decreased oxygen availability and transmits this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, an altered energy metabolism, as well as cell survival decisions. Among recent advances are the discoveries that reactive nitrogen species (RNS), oxygen species (ROS), cytokines, and growth factors participate in stability regulation of HIF-1α and HIF-1 transactivation during normoxia. Here we summarize current knowledge and existing concepts that help to understand how NO affects protein accumulation of HIF-1α. Considering the fundamental role of radicals, especially NO, as signaling molecules makes HIF-1α an attractive target under conditions of NO formation that may be attributed to both, physiology and pathology. Although initial observations showed that NO inhibits hypoxia-induced HIF-1α stabilization and HIF-1 transcriptional activation, later studies indicated that exposure of various cells to chemically diverse NO donors or conditions of endogenous NO formation under normoxic conditions induced HIF-1α accumulation, HIF-1-DNA binding, and activation of downstream target gene expression. These contrasting situations evoked by NO provide insights into basic chemical reactions, biochemical signal transduction pathways with broad implications for medicine.
Export Options
About this article
Cite this article as:
Brune Bernhard and Zhou Jie, The Role of Nitric Oxide (NO) in Stability Regulation of Hypoxia Inducible Factor-1α (HIF-1α), Current Medicinal Chemistry 2003; 10 (10) . https://dx.doi.org/10.2174/0929867033457746
DOI https://dx.doi.org/10.2174/0929867033457746 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry Postprandial Lipemia in Children and Adolescents
Current Vascular Pharmacology Lipoproteins in Atherosclerosis Process
Current Medicinal Chemistry Concerns and Hopes for Stem Cell Therapy in Cardiology: Focus on Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets The Role of the Endothelium in the Pathogenesis of Atherosclerosis and its Therapeutic Implications
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Current Pharmaceutical Design (Pro)renin Receptor: Pathological Role and Therapeutic Potential in Primary Hypertension
Current Hypertension Reviews The Coronary Collateral Circulation in Man
Current Cardiology Reviews Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) The Fetal Cardiac Function
Current Cardiology Reviews Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Vascular Endothelin and Hypertension - From Receptors to Medicine
Current Hypertension Reviews Noncardiac Surgery: Evaluating and Minimizing Cardiac Risk
Current Cardiology Reviews Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology Biological Abilities of Rice Bran-Derived Antioxidant Phytochemicals for Medical Therapy
Current Topics in Medicinal Chemistry Control of Copper Status for Cancer Therapy
Current Cancer Drug Targets Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?
Current Pharmaceutical Design Mechanisms of Focal Adhesion Kinase Regulation
Current Cancer Drug Targets Sol - Gel Technique Applied for Biomaterials Achievement
Recent Patents on Materials Science